https://www.selleckchem.com/pr....oducts/bms-986158.ht
e variation caused by study design factors and maximize interpretability of forthcoming studies for use in clinical guidelines and decision-making.Patients with congenital heart disease frequently have aneurysms or coronary artery fistulae that necessitate treatment. Metal vascular coils have been a mainstay of treatment for these lesions. In 2002, coils coated or filled with expandable hydrogel were introduced to treat cerebral aneurysms; however, the literature on their use in patients with congenital heart disease is limited. We p